Showing results (31-40 of 454) with videos related to

Sort By:
Pageof 46
Experimental and Clinical Endocrinology|April 1, 1984
Insulin resistance in diabetics and non-diabetics with impaired triglyceride removalU Julius, W Leonhardt, J Schulze, et al.
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete|April 1, 1987
[Presentation of an insulin-treated patient group within the scope of a 5-year study of the Diabetes Intervention Study (DIS)]J Lindner, A Dempe, G Neubert, et al.
Annals of Clinical Research|January 1, 1988
More exercise for the hyperlipidaemic patients?M Hanefeld, S Fischer, U Julius, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 17, 1998
Prevalence of diabetes-specific autoantibodies in patients at risk for adult onset diabetes mellitusM Breidert, T Temelkova-Kurktschiev, M Hanefeld, et al.
Arzneimittel-Forschung|December 1, 1988
Effects of a bezafibrate sustained release formulation on plasma lipoproteins in patients with hypercholesterolemia. Importance of timing of tablet intake for efficacyM Hanefeld, P D Lang, S Fischer, et al.
Diabetes, Nutrition & Metabolism|June 13, 2002
Impaired glucose tolerance is not associated with lipid intoleranceE Henkel, Th Temelkova-Kurktschiev, C Koehler, et al.
Biochimica Et Biophysica Acta|January 3, 1995
Very fast ultracentrifugation of serum lipoproteins: influence on lipoprotein separation and compositionJ Pietzsch, S Subat, S Nitzsche, et al.
The Clinical Investigator|July 1, 1994
Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal womenU Julius, H Fritsch, W Fritsch, et al.
Diabetes Care|December 29, 2000
Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c levelT S Temelkova-Kurktschiev, C Koehler, E Henkel, et al.
Atherosclerosis|October 1, 1984
Reduced incidence of cardiovascular complications and mortality in hyperlipoproteinemia (HLP) with effective lipid correction. The Dresden HLP studyM Hanefeld, C Hora, J Schulze, et al.
Pageof 46